These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 11353612

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antibacterial activity of telithromycin (HMR 3647) in relation to in vitro simulated human plasma kinetics.
    Bonnefoy A, Le Priol P.
    J Antimicrob Chemother; 2001 Apr; 47(4):471-3. PubMed ID: 11266424
    [Abstract] [Full Text] [Related]

  • 3. The ketolides: a critical review.
    Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A, Embil JM, Gin AS, Douthwaite S, Hoban DJ.
    Drugs; 2002 Apr; 62(12):1771-804. PubMed ID: 12149046
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
    Denis A, Agouridas C, Auger JM, Benedetti Y, Bonnefoy A, Bretin F, Chantot JF, Dussarat A, Fromentin C, D'Ambrières SG, Lachaud S, Laurin P, Le Martret O, Loyau V, Tessot N, Pejac JM, Perron S.
    Bioorg Med Chem Lett; 1999 Nov 01; 9(21):3075-80. PubMed ID: 10560728
    [Abstract] [Full Text] [Related]

  • 5. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
    Okamoto H, Miyazaki S, Tateda K, Ishii Y, Yamaguchi K.
    Antimicrob Agents Chemother; 2001 Nov 01; 45(11):3250-2. PubMed ID: 11600393
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F, Carnegy F, Willcock J, Amyes S.
    J Antimicrob Chemother; 2004 May 01; 53(5):793-6. PubMed ID: 15056640
    [Abstract] [Full Text] [Related]

  • 7. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
    Buxbaum A, Forsthuber S, Graninger W, Georgopoulos A.
    J Antimicrob Chemother; 2003 Sep 01; 52(3):371-4. PubMed ID: 12888585
    [Abstract] [Full Text] [Related]

  • 8. Telithromycin: the first of the ketolides.
    Shain CS, Amsden GW.
    Ann Pharmacother; 2002 Mar 01; 36(3):452-64. PubMed ID: 11895060
    [Abstract] [Full Text] [Related]

  • 9. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model.
    Tessier PR, Mattoes HM, Dandekar PK, Nightingale CH, Nicolau DP.
    Antimicrob Agents Chemother; 2005 Jan 01; 49(1):188-94. PubMed ID: 15616295
    [Abstract] [Full Text] [Related]

  • 10. [Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections].
    Casellas JM, Visser M, Mac Dougall N, Coco B, Tomé G, Gliosca L, Grupo Colaborativo de Telitromicina del Cono Sur.
    Rev Esp Quimioter; 2001 Sep 01; 14(3):269-74. PubMed ID: 11753448
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.
    Odenholt I, Löwdin E, Cars O.
    Antimicrob Agents Chemother; 2001 Jan 01; 45(1):23-9. PubMed ID: 11120939
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
    Muller-Serieys C.
    Presse Med; 2000 Dec 02; 29(37):2061-4. PubMed ID: 11155736
    [Abstract] [Full Text] [Related]

  • 16. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
    Nagai K, Davies TA, Ednie LM, Bryskier A, Palavecino E, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2001 Nov 02; 45(11):3242-5. PubMed ID: 11600391
    [Abstract] [Full Text] [Related]

  • 17. Comparison of telithromycin, a new ketolide, with erythromycin and clarithromycin for the treatment of Haemophilus influenzae pneumonia in suckling, middle aged and senescent mice.
    Thadepalli H, Chuah SK, Iskandar L, Gollapudi S.
    Int J Antimicrob Agents; 2002 Sep 02; 20(3):180-5. PubMed ID: 12385696
    [Abstract] [Full Text] [Related]

  • 18. Telithromycin: the first ketolide antimicrobial.
    Nguyen M, Chung EP.
    Clin Ther; 2005 Aug 02; 27(8):1144-63. PubMed ID: 16199242
    [Abstract] [Full Text] [Related]

  • 19. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections.
    Lonks JR, Goldmann DA.
    Clin Infect Dis; 2005 Jun 01; 40(11):1657-64. PubMed ID: 15889365
    [Abstract] [Full Text] [Related]

  • 20. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K, Credito K, Pankuch GA, Hoellman D, Lin G, Clark C, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2004 Nov 01; 48(11):4113-9. PubMed ID: 15504829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.